01 — Answers
Can I compound peptide X, in state Y, as facility type Z, today?
Clear status with federal 503A Bulks List chain step, PCAC docket, state board position, effective dates, and linked citations. Replaces the lawyer call for the first pass.
02 — Paperwork
Compliant documents, merge-filled in one click.
Informed consent, Rx documentation checklist, and supplier/COA verification — generated against the rule version in effect at that moment.
03 — Proof
When a board asks why you thought it was legal, export the packet.
Every lookup and document is timestamped. History is append-only. The audit trail is the product.
Built for how you operate
Common questions
What is PeptSense?
PeptSense is regulatory intelligence software for peptide compliance. It answers whether a peptide can be compounded or offered in a given state and facility type, with federal and state citations, generated paperwork, and a timestamped audit trail.
Who uses PeptSense?
503A compounding pharmacies, peptide clinics, and individual prescribers who need a maintained source of truth instead of attorney memos, Facebook groups, or spreadsheets.
Does PeptSense provide legal advice?
No. PeptSense is informational only. It helps teams research regulatory posture and document what they checked. Always confirm with counsel and the authorities that regulate your facility.
Which peptides are tracked?
The MVP formulary covers 19 commonly compounded and PCAC-watched peptides including semaglutide, tirzepatide, BPC-157, TB-500, CJC-1295, ipamorelin, and others. See the full peptide index for aliases and regulatory context.
How is federal peptide status determined?
Federal posture follows FDA’s 503A Bulks List framework: on the list, USP monograph path, approved-drug component, interim enforcement discretion, and PCAC advisory context. PeptSense walks that chain with citations — not legacy Category 1/2 labels.